First Time Loading...

Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 45.3 USD 1.98% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

LEGN Price Targets Summary
Legend Biotech Corp

Wall Street analysts forecast LEGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LEGN is 87.88 USD with a low forecast of 65.65 USD and a high forecast of 99.75 USD.

LEGN Lowest Forecast
Wall Street Target
65.65 USD
45% Upside
LEGN Average Forecast
Wall Street Target
87.88 USD
94% Upside
LEGN Highest Forecast
Wall Street Target
99.75 USD
120% Upside
Lowest
Price Target
65.65 USD
45% Upside
Average
Price Target
87.88 USD
94% Upside
Highest
Price Target
99.75 USD
120% Upside

LEGN Last Price Targets
Legend Biotech Corp

The latest public price target was made on Apr 17, 2024 by George Farmer from Scotiabank , who expects LEGN stock to rise by 43% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
George Farmer
Scotiabank
65 USD
Upside 43%
1 week ago
Apr 17, 2024
Scotiabank Upgrades Legend Biotech Corp. (LEGN) to Sector Outperform
StreetInsider
Rick Bienkowski
Cantor Fitzgerald
82 USD
Upside 81%
3 weeks ago
Apr 3, 2024
Cantor Fitzgerald Starts Legend Biotech Corp. (LEGN) at Overweight
StreetInsider
Kostas Biliouris
BMO Capital
90 USD
Upside 99%
1 month ago
Mar 14, 2024
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
StreetInsider
George Farmer
Scotiabank
Price Target 65 USD
Upside/Downside 43%
View Source
Rick Bienkowski
Cantor Fitzgerald
Price Target 82 USD
Upside/Downside 81%
View Source
Kostas Biliouris
BMO Capital
Price Target 90 USD
Upside/Downside 99%
View Source
Legend Biotech Corp Competitors:
Price Targets
BIOCON
Biocon Ltd
6% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
4% Upside
IMTX
Immatics NV
91% Upside
688363
Bloomage Biotechnology Corp Ltd
61% Upside
BIOCON
Biocon Ltd
6% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
4% Upside
IMTX
Immatics NV
91% Upside
688363
Bloomage Biotechnology Corp Ltd
61% Upside
S
002880
Shenzhen Weiguang Biological Products Co Ltd
48% Upside
PRLD
Prelude Therapeutics Inc
45% Upside
DNLI
Denali Therapeutics Inc
172% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Legend Biotech Corp

For the last 5 years the compound annual growth rate for Legend Biotech Corp's revenue is 42%. The projected CAGR for the next 3 years is 81%.

42%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
What are analyst estimates?

See Also

Summary
LEGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
LEGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LEGN stock valuation using valuation multiples.
Wall Street Estimates
LEGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LEGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LEGN's stock price target?
Price Target
87.88 USD

According to Wall Street analysts, the average 1-year price target for LEGN is 87.88 USD with a low forecast of 65.65 USD and a high forecast of 99.75 USD.

What is Legend Biotech Corp's Revenue forecast?
Projected CAGR
81%

For the last 5 years the compound annual growth rate for Legend Biotech Corp's revenue is 42%. The projected CAGR for the next 3 years is 81%.

ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.